We are live on ! Find out more
VIVS

VivoSim Labs

33 hedge funds and large institutions have $1.77M invested in VivoSim Labs in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more capital invested

Capital invested by funds: $912K → $1.77M (+$862K)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

6% more funds holding

Funds holding: 3133 (+2)

0.62% more ownership

Funds ownership: 0.73%1.35% (+0.62%)

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
9
Reduced
6
Closed
4
Calls
$14K
Puts
Net Calls
+$14K
Net Calls Change
-$3K

VIVS Hedge Fund Activity: Q2 2024 in Review

33 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2024, worth a combined $1.77M — up 94% from $912K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VIVS positions and 4 closed out — a net gain of 2 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $914K. The largest seller was Renaissance Technologies, cutting an estimated $33.8K.

  • 33 institutional investors held VivoSim Labs (VIVS) as of Q2 2024, up from 31 in Q1 2024.
  • Funds reported $1.77M of VivoSim Labs stock for Q2 2024, up 94% quarter-over-quarter.
  • 6 funds opened new VivoSim Labs positions in Q2 2024 and 4 closed out, a net change of +2 holders.
  • The largest VivoSim Labs buyer in Q2 2024 was Armistice Capital, an estimated $914K added.
  • The largest VivoSim Labs seller in Q2 2024 was Renaissance Technologies, an estimated $33.8K sold.

Based on aggregated 13F filings for Q2 2024.